Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…ontrol and stroke prevention, using rate-controlling agents and anticoagulants. These medications can lead to various adverse events such as h…
…l strain (basal, mid and apical) and strain patterns between RT IPED users and RT non-user controls.Methods Utilising a cross-sectio…
… include Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2i) or ivabradine and was restricted to HFrEF.We have here introduced the Blackpo…
…ntion populations.2 This analysis assesses the effectiveness of bempedoic acid, a non-statin lipid-lowering therapy, in achieving NICE non-HDL…
…Anti-arrhythmic (AAD) use pre-procedure (amiodarone/dronedarone/flecainide/sotalol)n=30 (60%)Abstract 303 Figure 2Abstract 303 Table 2Proc…
…ibrotic response in CFs to mechanical stretch. CFs responded to TGFβ1 by increasing fibrotic markers. We observed a pH-dependent TGF-…
…; Arg1flox/flox mice were used to target Arg1 in macrophages by tamoxifen induction, and animals underwent permanent coronary ligation wi…
… of Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2i). Use of Ivabradine (if heart rate ≥70 bpm in sinus rhythm) and hydralazine–isosorb…
…ct9 Table 1Characteristics of included cohort studies comparing pregabalin and gabapentinStudyStudy populationBaseline HF statusHF outcome…
…rial metabolism and circadian programmes reduced) attenuated by navitoclax. Collectively, these analyses place senescent-cell clearance as…
…have recommended that patients with a BNP>2000 and those with a BNP 400-2000, should be reviewed by a HF specialist within two and …
…th benzodiazepines (BDZ) (t=−5.737; p<0.001) and treatment with atypical antipsychotics (t=3.104; p=0.002).Conclusions CLP interventions in our high-co…